• Insider Moves: Palatin, Dollar Tree, Coupang, Coherent, Bausch TipRanks Sat, 21 Jun 2025 13:09:32 GMT
• palatin technologies announces closing of reduced public offering (pr newswire) Aktiellt Fri, 20 Jun 2025 09:33:26 GMT
• Palatin Technologies Executives Make Massive Stock Purchases! TipRanks Tue, 17 Jun 2025 07:00:00 GMT
• palatin technologies (pali) teams up with key managers for investment strategy | pali stock news GuruFocus Tue, 27 May 2025 07:00:00 GMT
• Palatin Technologies, Inc. (AMEX:PTN) Q3 2025 Earnings Call Transcript MSN Sun, 25 May 2025 21:02:46 GMT
• palatin technologies, inc. (amex:ptn) q3 2025 earnings call transcript MSN Thu, 22 May 2025 02:38:44 GMT
• palatin technologies, inc. (amex:ptn) q3 2025 earnings call transcript Insider Monkey Tue, 20 May 2025 07:00:00 GMT
• palatin technologies (nyse:ptn) coverage initiated by analysts at stocknews.com Defense World Tue, 20 May 2025 07:00:00 GMT
• moderate dry eye market growth to accelerate in forecast period (2023-2032), delveinsight analyzes | mc2 therapeutics, palatin tec... The Globe and Mail Thu, 15 May 2025 14:46:00 GMT
• palatin reports fiscal year 2025 third quarter results and business update The Malaysian Reserve Thu, 15 May 2025 10:06:11 GMT
• Palatin Technologies Inc (PTNT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... Yahoo Finance Thu, 15 May 2025 07:00:00 GMT
• earnings call transcript: palatin’s q3 fy2025 shows narrower loss by investing.com Investing.com Nigeria Thu, 15 May 2025 02:19:53 GMT
• Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update PR Newswire Wed, 14 May 2025 07:00:00 GMT
• Earnings call transcript: Palatin’s Q3 FY2025 shows narrower loss Investing.com Wed, 14 May 2025 07:00:00 GMT
• palatin's new obesity drug shows 4.4% weight loss when combined with popular glp-1 treatment Stock Titan Wed, 14 May 2025 07:00:00 GMT
• palatin technologies (ptn) to release quarterly earnings on wednesday Defense World Wed, 14 May 2025 07:00:00 GMT
• palatin technologies (nyse:ptn) coverage initiated by analysts at stocknews.com Defense World Tue, 13 May 2025 07:09:58 GMT
• palatin technologies director robert deveer buys $10,180 in stock by investing.com Investing.com Nigeria Tue, 13 May 2025 02:10:03 GMT
• Palatin Technologies director Robert DeVeer buys $10,180 in stock Investing.com Mon, 12 May 2025 07:00:00 GMT
• palatin technologies (nyse:ptn) coverage initiated by analysts at stocknews.com Defense World Mon, 12 May 2025 07:00:00 GMT
• palatin reveals potential diabetic retinopathy treatments Investing.com Sat, 10 May 2025 10:12:31 GMT
• biotech alert: searches spiking for these stocks today Yahoo Finance Sat, 10 May 2025 07:00:00 GMT
• two new option listings and two option delistings on may 9th TipRanks Fri, 09 May 2025 15:24:45 GMT
• palatin expects $11.5m financing to cure nyse american delisting notice MSN Fri, 09 May 2025 08:21:18 GMT
• Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025 PR Newswire Fri, 09 May 2025 07:00:00 GMT
• Palatin Technologies (PTNT): A High-Risk Gamble Amid Financial Strains and Regulatory Setbacks AInvest Fri, 09 May 2025 07:00:00 GMT
• palatin technologies announces closing of reduced public offering Financial Times Fri, 09 May 2025 07:00:00 GMT
• palatin unveils promising preclinical data for diabetic retinopathy treatments at arvo 2025 Nasdaq Fri, 09 May 2025 07:00:00 GMT
• palatin reveals potential diabetic retinopathy treatments Investing.com Fri, 09 May 2025 07:00:00 GMT
• Palatin Technologies Announces Closing of Reduced Public Offering PR Newswire Thu, 08 May 2025 07:00:00 GMT
• Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025 Yahoo Finance Thu, 08 May 2025 07:00:00 GMT
• Palatin Technologies (PTN) Reveals Promising Phase 3 Study Results for PL9643 in Dry Eye Disease | PTN Stock News GuruFocus Thu, 08 May 2025 07:00:00 GMT
• ptn faces delisting from nyse american, shares transition to otc market | ptn stock news GuruFocus Thu, 08 May 2025 07:00:00 GMT
• palatin technologies announces transition to otc pink following nyse american delisting notice | ptn stock news GuruFocus Thu, 08 May 2025 07:00:00 GMT
• Palatin Technologies Announces Pricing of up to $23 Million Public Offering PR Newswire Wed, 07 May 2025 07:00:00 GMT
• Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice Stock Titan Wed, 07 May 2025 07:00:00 GMT
• Palatin Expects $11.5 Million Financing to Cure NYSE American Delisting Notice PR Newswire Wed, 07 May 2025 07:00:00 GMT
• Palatin Technologies sets terms for $23 million offering Investing.com Wed, 07 May 2025 07:00:00 GMT
• NYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN) Business Wire Wed, 07 May 2025 07:00:00 GMT
• Palatin Technologies faces delisting from NYSE American due to low stock price Investing.com Wed, 07 May 2025 07:00:00 GMT
• Palatin Expects $11.5 Mln Offering To Aid NYSE Compliance And Fuel Obesity Drug Development Nasdaq Wed, 07 May 2025 07:00:00 GMT
• palatin secures $11.5 million to tackle nyse delisting, boost obesity drugs Investing.com Canada Wed, 07 May 2025 07:00:00 GMT
• palatin technologies stock trading halted pending material announcement MarketScreener Wed, 07 May 2025 07:00:00 GMT
• palatin (ptn) aims to address delisting concerns with public offering | ptn stock news GuruFocus Wed, 07 May 2025 07:00:00 GMT
• palatin (ptn) unveils promising data for glaucoma treatment cand GuruFocus Mon, 05 May 2025 15:39:58 GMT
• Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Ther... PR Newswire Mon, 05 May 2025 07:00:00 GMT
• Palatin Technologies Announces Encouraging Pre-Clinical Data Of PL9588 For Glaucoma Treatment Nasdaq Mon, 05 May 2025 07:00:00 GMT
• Breakthrough Dual-Action Glaucoma Therapy Shows 25% Cell Protection in Trial Data | PTN Stock News Stock Titan Mon, 05 May 2025 07:00:00 GMT
• palatin technologies (nyse:ptn) coverage initiated at stocknews.com Defense World Sun, 04 May 2025 07:00:00 GMT
• palatin provides update from pivotal phase 3 melody-1 clinical trial TipRanks Tue, 29 Apr 2025 13:22:45 GMT
• palatin (ptn) announces promising results for pl9643 in dry eye disease study | ptn stock news GuruFocus Tue, 29 Apr 2025 13:08:52 GMT
• Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disea... PR Newswire Tue, 29 Apr 2025 07:00:00 GMT
• Palatin releases updated results from responder analyses of phase 3 MELODY-1 trial in dry eye Ophthalmology Times Tue, 29 Apr 2025 07:00:00 GMT
• first-ever complete symptom resolution: game-changing phase 3 results in $6b dry eye market Stock Titan Tue, 29 Apr 2025 07:00:00 GMT
• palatin reports positive results from responder analyses of phase 3 melody-1 study in ded Nasdaq Tue, 29 Apr 2025 07:00:00 GMT
• investor network: palatin technologies, inc. to host earnings call ACCESS Newswire Sun, 27 Apr 2025 17:45:37 GMT
• nyse to commence delisting proceedings against solo brands, inc. (dtc) Business Wire Tue, 22 Apr 2025 20:12:00 GMT
• palatin concludes phase ii trial of combination therapy for obesity MSN Tue, 22 Apr 2025 18:49:11 GMT
• palatin’s obesity study shows promise in appetite control by investing.com Investing.com Canada Fri, 18 Apr 2025 03:45:17 GMT
• dry eye disease market growth projections 2024-2034: delveinsight analysis | palatin technologies, novaliq, mc2 therapeutics The Globe and Mail Thu, 17 Apr 2025 13:56:30 GMT
• palatin (ptn) reports positive phase 2 study results for obesity treatment | ptn stock news GuruFocus Thu, 17 Apr 2025 12:01:39 GMT
• Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide PR Newswire Thu, 17 Apr 2025 07:00:00 GMT
• Breakthrough Obesity Treatment Shows 71% Appetite Control, Blocks Post-Treatment Weight Rebound Stock Titan Thu, 17 Apr 2025 07:00:00 GMT
• Palatin’s obesity study shows promise in appetite control Investing.com Thu, 17 Apr 2025 07:00:00 GMT
• palatin appeals nyse american notice of delisting Kilgore News Herald Tue, 15 Apr 2025 12:49:58 GMT
• palatin technologies (ptn) appeals nyse delisting decision | ptn stock news GuruFocus Tue, 15 Apr 2025 05:50:48 GMT
• Palatin Launches Bold Defense Against NYSE Delisting: Multi-Strategy Rescue Plan Revealed Stock Titan Mon, 14 Apr 2025 07:00:00 GMT
• Palatin Appeals NYSE Delisting, Pursues Financing And Partnerships To Regain Compliance Nasdaq Mon, 14 Apr 2025 07:00:00 GMT
• palatin contests nyse american delisting notice by investing.com Investing.com Canada Mon, 14 Apr 2025 07:00:00 GMT
• palatin appeals nyse american notice of delisting | ptn stock ne GuruFocus Mon, 14 Apr 2025 07:00:00 GMT
• palatin technologies (ptn) appeals nyse delisting decision | ptn stock news GuruFocus Mon, 14 Apr 2025 07:00:00 GMT
• stock slump: eyewear innovator and tech firms face market hits Finimize Sat, 12 Apr 2025 05:51:15 GMT
• Stock Slump: Eyewear Innovator And Tech Firms Face Market Hits Finimize Fri, 11 Apr 2025 19:37:59 GMT
• palatin technologies (ptn) faces nyse american delisting proceedings GuruFocus Fri, 11 Apr 2025 16:18:09 GMT
• palatin (ptn) faces delisting proceedings from nyse american | p GuruFocus Fri, 11 Apr 2025 16:07:43 GMT
• palatin to present positive phase 2b data for melanocortin agoni GuruFocus Fri, 11 Apr 2025 07:14:02 GMT
• Palatin Technologies faces delisting over equity shortfall The Pharma Letter Fri, 11 Apr 2025 07:00:00 GMT
• Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX Stocktwits Fri, 11 Apr 2025 07:00:00 GMT
• palatin concludes phase ii trial of combination therapy for obesity MSN Thu, 10 Apr 2025 21:17:25 GMT
• palatin technologies shares fall as it receives nyse american delisting notice MSN Thu, 10 Apr 2025 20:31:17 GMT
• palatin receives nyse american notice of delisting, plans to appeal TipRanks Thu, 10 Apr 2025 20:07:45 GMT
• 2025-04-10 | palatin to present positive phase 2b data for melanocortin agonist in diabetic kidney disease at the national kidney ... Stockhouse Thu, 10 Apr 2025 11:30:00 GMT
• Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal PR Newswire Thu, 10 Apr 2025 07:00:00 GMT
• Palatin Technologies faces potential NYSE American delisting Investing.com Thu, 10 Apr 2025 07:00:00 GMT
• Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Sp... PR Newswire Thu, 10 Apr 2025 07:00:00 GMT
• palatin technologies reports positive data from phase 2b breakout study Nasdaq Thu, 10 Apr 2025 07:00:00 GMT
• nyse american to commence delisting proceedings against palatin technologies, inc. (ptn) Business Wire Thu, 10 Apr 2025 07:00:00 GMT
• nyse american moves to delist palatin technologies: company fighting back Stock Titan Thu, 10 Apr 2025 07:00:00 GMT
• palatin reports promising kidney disease treatment results Investing.com Thu, 10 Apr 2025 07:00:00 GMT
• palatin technologies (ptn) faces nyse american delisting proceedings GuruFocus Thu, 10 Apr 2025 07:00:00 GMT
• breakthrough: new drug shows 71% success rate in diabetic kidney disease trial Stock Titan Thu, 10 Apr 2025 07:00:00 GMT
• palatin (ptn) faces delisting proceedings from nyse american | p GuruFocus Thu, 10 Apr 2025 07:00:00 GMT
• stock slump: eyewear innovator and tech firms face market hits Finimize Wed, 09 Apr 2025 07:00:00 GMT
• dry eye disease market to expand significantly by 2034, states openPR.com Wed, 09 Apr 2025 07:00:00 GMT
• palatin says bmt-801 phase 2 obesity study met primary endpoint TipRanks Mon, 31 Mar 2025 13:45:28 GMT
• Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity ... PR Newswire Mon, 31 Mar 2025 07:00:00 GMT
• Palatin touts synergistic weight loss effect with MC4R agonist, Zepbound combo FirstWord Pharma Mon, 31 Mar 2025 07:00:00 GMT
• Breakthrough Obesity Treatment: New Drug Combo Achieves 4.4% Weight Loss in Clinical Trial Stock Titan Mon, 31 Mar 2025 07:00:00 GMT
• Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight Benzinga Mon, 31 Mar 2025 07:00:00 GMT
• palatin technologies’ uc treatment shows remarkable 78% clinical response rate in phase 2 topline data – potential game-changer fo... Barchart.com Mon, 31 Mar 2025 07:00:00 GMT
• palatin reported promising results in trial for ulcerative colitis treatment MSN Sun, 30 Mar 2025 11:23:01 GMT
• palatin reported promising results in trial for ulcerative colitis treatment MSN Sat, 29 Mar 2025 00:17:41 GMT
• palatin technologies' ulcerative colitis drug candidate shows positive results in phase 2 study MarketScreener Fri, 28 Mar 2025 14:50:56 GMT
• ptn stock touches 52-week low at $0.67 amid market challenges Investing.com UK Fri, 28 Mar 2025 13:32:00 GMT
• Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL81... PR Newswire Fri, 28 Mar 2025 07:00:00 GMT
• Palatin’s UC therapy prompts clinical remission in a third of patients Clinical Trials Arena Fri, 28 Mar 2025 07:00:00 GMT
• palatin’s pl8177 shows promise in ulcerative colitis study by investing.com Investing.com Australia Fri, 28 Mar 2025 07:00:00 GMT
• palatin technologies reports positive data from phase 2 study of pl8177 in ulcerative colitis Nasdaq Fri, 28 Mar 2025 07:00:00 GMT
• palatin technologies touts positive results from mid-stage study for experimental drug for ulcerative colitis, halts patients enro... Benzinga Fri, 28 Mar 2025 07:00:00 GMT
• breakthrough: novel uc treatment achieves 78% response rate, big pharma circling Stock Titan Fri, 28 Mar 2025 07:00:00 GMT
• palatin reported promising results in trial for ulcerative colitis treatment (ptn:nyse) Seeking Alpha Fri, 28 Mar 2025 07:00:00 GMT
• palatin reports ‘positive’ results from phase 2 study of pl8177 TipRanks Fri, 28 Mar 2025 07:00:00 GMT
• palatin technologies (nyseamerican:ptn) share price passes above 200 day moving average – what’s next? Defense World Thu, 27 Mar 2025 07:28:45 GMT
• palatin technologies' obesity drug receives fda orphan designation; phase 2 results imminent (nyse: ptn) openPR.com Thu, 27 Mar 2025 07:00:00 GMT
• Palatin Drug Gets FDA’s Orphan Nod for Rare Type of Obesity Inside Precision Medicine Wed, 26 Mar 2025 07:00:00 GMT
• US FDA grants orphan drug status to Palatin’s obesity treatment PL7737 Pharmaceutical Business review - Wed, 26 Mar 2025 07:00:00 GMT
• palatin’s dual blockbuster potential: obesity and ulcerative colitis results expected within days NewsBlaze Tue, 25 Mar 2025 12:31:48 GMT
• palatin reports second quarter fiscal year 2025 financial results and provides business update The Victoria Advocate Tue, 25 Mar 2025 12:17:44 GMT
• Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency PR Newswire Tue, 25 Mar 2025 07:00:00 GMT
• breakthrough: fda backs palatin's novel oral drug for rare genetic obesity condition Stock Titan Tue, 25 Mar 2025 07:00:00 GMT
• palatin’s obesity drug gains fda orphan status by investing.com Investing.com Canada Tue, 25 Mar 2025 07:00:00 GMT
• palatin stock gains on fda orphan drug status (ptn:nyse) Seeking Alpha Tue, 25 Mar 2025 07:00:00 GMT
• palatin technologies (nyseamerican:ptn) share price passes above 200 day moving average – time to sell? Defense World Wed, 19 Mar 2025 07:50:37 GMT
• Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance Thu, 13 Mar 2025 07:00:00 GMT
• palatin technologies (nyseamerican:ptn) shares pass above two hundred day moving average – time to sell? Defense World Tue, 11 Mar 2025 07:00:00 GMT
• palatin reports second quarter fiscal year 2025 financial results and provides business update GuruFocus.com Sun, 09 Mar 2025 12:47:52 GMT
• palatin awaits data release from phase 2 trial of bremelanotide-tirzepatide combo in weight loss RTTNews Mon, 24 Feb 2025 08:05:00 GMT
• palatin secures $4.7 million in stock and warrant sale by investing.com Investing.com Nigeria Thu, 20 Feb 2025 09:05:27 GMT
• hc wainwright cuts palatin technologies (nyseamerican:ptn) price target to $7.00 Armenian Reporter Sun, 16 Feb 2025 16:07:35 GMT
• palatin reports second quarter fiscal year 2025 financial results and provides business update br.ADVFN.com Sun, 16 Feb 2025 06:39:28 GMT
• hc wainwright issues pessimistic forecast for palatin technologies (nyseamerican:ptn) stock price Defense World Sat, 15 Feb 2025 08:00:00 GMT
Palatin Technologies, Inc(NYSE MKT:PTN) 
Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acqui...
Website: http://www.palatin.com
Founded: 1986
Full Time Employees: 20
Sector: Healthcare
Industry: Biotechnology